Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Treatment in Patients With Ischemic Heart Failure and Circulating Levels of NT-proBNP

NCT04420481 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT04420481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Treatment in Patients With Ischemic Heart Failure and Circulating Levels of NT-proBNP
Lead sponsor
Göteborg University
Phase
Phase 3
Overall status
Completed
Start date
April 28, 2004
Completion date
February 25, 2012
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, systolic, ischemic heart disease chronic